Integrated Biopharma, Inc.
INBP
$0.32
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.51% | -166.42% | 114.39% | 130.37% | 538.98% |
| Total Depreciation and Amortization | 2.19% | 3.15% | 0.00% | 5.30% | 7.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.57% | 514.39% | 81.69% | 1,488.89% | 208.54% |
| Change in Net Operating Assets | 517.71% | 54.73% | -161.07% | 79.40% | -117.64% |
| Cash from Operations | 98.02% | 417.74% | -62.51% | 111.00% | -49.96% |
| Capital Expenditure | -208.93% | 106.85% | 66.38% | -20.83% | -47.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -208.93% | 97.26% | 66.38% | -20.83% | -47.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -57.14% | 90.91% | 100.00% | 100.00% | 30.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.14% | 709.09% | 100.00% | 263.64% | -333.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 88.05% | 290.67% | -61.18% | 110.20% | -53.52% |